英文_EFPIA_阿尔茨海默病医疗之旅的未来验证_13页_2mb

Alzheimer's Disease Healthcare Journey: Emerging Best Practices Across Europe

Executive Summary

• Alzheimer's Disease (AD) diagnosis and care are being transformed by DMTs, biomarkers, and digital solutions.
• Europe is experiencing a shift toward proactive, data-informed, and person-centered models of AD care through localized initiatives.
• Persistent gaps include uneven access, workforce shortages, stigma, and inadequate public awareness.
• Policymakers are urged to invest in national strategies, fund research, empower primary care, and accelerate trans-sector partnerships.

Key Challenges

1. Fragmented care pathways with delayed detection.
2. Inconsistent use of diagnostic tools and long wait times.
3. Stigma and underutilization of primary care in early detection.
4. Persistent workforce shortages and funding constraints.

Recommendations for Policymakers

• Prioritize early diagnosis through accessible diagnostic tools and infrastructure.
• Fund workforce training and incentive programs for primary care providers.
• Scale up multidisciplinary care pathways and integrate data systems.
• Foster collaborations between research, healthcare providers, and technology developers.
• Develop national dementia registries to improve care monitoring and policy planning.

Emerging Best Practices by Theme

1. Tools and Approaches for Early Detection and Diagnosis

• Digital Cognitive Testing: Apps like neotivCare and Cogni Trainee offer home-based assessments, improving accessibility and reducing clinician workload by up to €150 per test.
• Blood-Based Biomarkers: The p-tau217 test demonstrated high diagnostic accuracy (78% confirmatory diagnosis) at lower costs than traditional methods.
• National Registries: Sweden’s SveDem tracks over 190,000 cases, enabling benchmarking and resource allocation.

2. Integrated and Multidisciplinary Care Paradigms

• Person-Centered Models: Memory clinics like Minnesmottagningen in Sweden shorten diagnostic timelines from 9 months to 4 weeks.
• Collaborative Networks: Programs like PASSCOG and DementiaNet empower GPs and connect community-based care with specialists.
• Case Example: NeuroProtect Center in Poland integrates diagnostics with clinical trials and multidisciplinary support, reducing long-term burdens.

3. Data-Driven Decision Making and System Optimisation

• Data Registries: The French National Alzheimer Database enhances care monitoring and treatment benchmarking.
• Real-Time Surveillance: Registries like SveDem provide timely insights into diagnosis and treatment disparities.
• Transparency: Open data platforms (e.g., Terrapino risk assessments) enhance public understanding and early help-seeking.

Policy Implications

• Stigma Reduction: Public awareness campaigns (e.g., PASSCOG) improve societal understanding and early detection.
• Primary Care Enablement: Training programs in countries like Germany equip GPs to manage early symptoms effectively.
• Trans-Sector Partnerships: Collaborations between industry, academia, and civil society accelerate translation of innovations.

Approach & Methodology

• Selection Criteria: Focused on actionable case studies from eight European countries (Czechia, France, Germany, Netherlands, Poland, Slovenia, Spain, Sweden).
• Criteria: Implementation in practice, cost-effectiveness, scalability, and policy relevance.
• Sources: Desk research, stakeholder interviews, and national reports.

Conclusion

AD care is evolving toward timely, equitable, and evidence-based models, utilizing digital tools and data systems. Urgent action is needed to overcome systemic barriers and ensure broad access to innovations, positioning Europe at the forefront of dementia care transformation.